Oseltamivir Dosing for a 22-lb Child
For a 22-lb (10 kg) child aged 12 months or older, give oseltamivir 30 mg twice daily for treatment or 30 mg once daily for prophylaxis. 1, 2
Weight-Based Dosing Algorithm
The most recent AAP guidelines (2025-2026) provide clear weight-based dosing for children ≥12 months 1:
- ≤15 kg (≤33 lb): 30 mg twice daily for treatment; 30 mg once daily for prophylaxis
- >15 to 23 kg (>33 to 51 lb): 45 mg twice daily for treatment; 45 mg once daily for prophylaxis
- >23 to 40 kg (>51 to 88 lb): 60 mg twice daily for treatment; 60 mg once daily for prophylaxis
- >40 kg (>88 lb): 75 mg twice daily for treatment; 75 mg once daily for prophylaxis
Since your patient weighs 22 lb (10 kg), they fall into the ≤15 kg category, requiring 30 mg twice daily for treatment.
Practical Administration Details
Oseltamivir is supplied as oral suspension (6 mg/mL concentration) or capsules 2:
- For a 30 mg dose: Give 5 mL of the 6 mg/mL suspension
- Administer with or without food (though giving with meals may reduce nausea/vomiting)
- Use an appropriate measuring device (3-mL or 5-mL oral syringe) for accurate dosing in young children 2
- Treatment duration: 5 days
- Prophylaxis duration: 7 days after last known exposure 1, 2
Critical Age Consideration
Verify the child's age before prescribing. If this child is younger than 12 months, different dosing applies 1:
- 9-11 months: 3.5 mg/kg per dose twice daily (approximately 35 mg for a 10 kg child)
- 0-8 months: 3 mg/kg per dose twice daily (approximately 30 mg for a 10 kg child)
- <3 months: Prophylaxis is NOT recommended by AAP or CDC due to limited safety data 1, 2
The AAP dosing for infants 9-11 months is higher than FDA-approved dosing and is based on pharmacokinetic data showing that higher doses are needed to achieve target drug exposure in this age group 1, 3.
Common Pitfalls to Avoid
Don't underdose based on FDA labeling alone: The AAP recommendations differ from FDA package insert dosing for certain age groups, particularly infants 9-11 months 1, 2
Don't use adult weight-based calculations: Children <12 years eliminate oseltamivir carboxylate faster than adults, requiring different dosing strategies 4, 3
Don't delay treatment: Oseltamivir should be initiated within 48 hours of symptom onset for optimal efficacy 2, 5
Watch for vomiting: Oseltamivir is associated with increased nausea (RR 1.43) and vomiting (RR 1.83) 6. If vomiting occurs within 1 hour of dosing, consider repeating the dose.
Safety Profile
Common adverse events include nausea, vomiting, headache, and skin reactions 2. The medication is generally well-tolerated in children, with discontinuation rates due to adverse events being low (1.8% vs 1.1% placebo) 5. Hypersensitivity reactions including anaphylaxis have been reported postmarketing 2.